Clinical trial
The Effect Of Ezetimibe In Addition To Optimal Cholesterol-Lowering Statin Therapy On The Plaque Composition In Patients With Acute Myocardial Infarction - Assessed By Optical Coherence Tomography And Intravascular Ultrasound.
NCT01385631 is registered in ClinicalTrials.gov with Odense University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect Of Ezetimibe In Addition To Optimal Cholesterol-Lowering Statin Therapy On The Plaque Composition In Patients With Acute Myocardial Infarction - Assessed By Optical Coherence Tomography And Intravascular Ultrasound.
- Lead sponsor
- Odense University Hospital
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- June 30, 2011
- Completion date
- September 30, 2014
- Enrollment
- 87 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
st-segment elevation myocardial infarction